Oxaliplatin might promote the apoptosis of BGC‐823 gastric cancer cells and slow the infiltration and metastasis of tumor cells by upregulating miR‐34a, activating the expression of the upstream P53 gene and joint promoting the downregulation of surviving. This evidence concerns the gene TP53 and gastric cancer.